Over the last 50 years, advances in surgical procedures, clinical understandings and targeted treatments have changed the prospects of many cancer diagnoses from terminal to treatable. However, this progress is not evenly distributed across the many different types of cancer, and nowhere is that more keenly felt than in cancers affecting children.  How might the advances and insights in treating blood cancers benefit patients with brain tumours?

To answer that question, I am speaking today with Dr David Walker and Dr Chris Halsey about their research connecting trials and treatments across disease types, for the benefit of all patients.

Read more: http://dx.doi.org/10.1016/S2352-4642(19)30333-5